Accelerating global chemical product innovation and development

Scientific and regulatory support to market and sustain your products in any jurisdiction.

Competitive Advantage

Acta is a global scientific and regulatory consulting firm that assists companies that make and use chemicals with strategic commercialization planning and complex product registration and compliance matters.

We partner with our clients to help them get products quickly and efficiently to market — in any country or locale — and keep them there when challenged by a new regulatory regime, issue, or set of rules.

More About Us

Knowledge & Insights

  September 12, 2025
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  December 16, 2025
Memoranda
Cracks in the Enamel: The Ascendance of Federal and State Action to Restrict Fluoride Use 

Fluoride, well-known for its anticavity properties, has seen a growing number of state and federal initiatives seeking to limit or prohibit various...

  December 8, 2025
Memoranda
EPA Begins Public Comment Period on Updated Draft Risk Calculation Memorandum for Formaldehyde

On December 3, 2025, the U.S. Environmental Protection Agency (EPA) announced the availability of and solicited public comment on an Updated Draft...

  December 5, 2025
Memoranda
European Union Deforestation Regulation Faces Likely Delay

The European Union Deforestation Regulation (EUDR) appears to be headed for yet another full-year delay following growing political pressure, concerns...

  December 2, 2025
Memoranda
White House OSTP Issues RFI Regarding “Accelerating the American Scientific Enterprise”

On Thanksgiving Eve, November 26, 2025, the White House Office of Science and Technology Policy (OSTP) requested input from interested parties on...

  November 25, 2025
Memoranda
EPA Publishes Default Values Used in New Chemical Risk Assessments under TSCA

On November 24, 2025, the U.S. Environmental Protection Agency (EPA) released the key default values that it uses in its risk assessments of new...

  November 13, 2025
Memoranda
EPA Proposes to Narrow Scope of TSCA Section 8(a)(7) PFAS Reporting Rule; Exemptions Would Include De Minimis Amounts, Imported Articles

On November 13, 2025, the U.S. Environmental Protection Agency (EPA) issued a proposed rule to amend the Toxic Substances Control Act (TSCA) Section...

Seminars & Webinars

  October 29, 2025
Seminars & Webinars
TSCA Developments 2026, February 5, 2026, via webinar

Chemical Watch presents TSCA Developments 2026, covering TSCA and its business-critical implications, including risk evaluation and management rules,...

  November 6, 2025
Seminars & Webinars
Environmental Law 2026, February 19-20, 2026, Washington, D.C. and via webcast

ALI CLE presents “Environmental Law 2026,” a two-day program on the latest developments across every major area of environmental law—from air,...

  December 9, 2025
Seminars & Webinars
GlobalChem, February 22-24, 2026, Washington, D.C.

GlobalChem, presented by the American Chemistry Council, brings together industry professionals to review recent developments in global chemicals...

With offices in the U.S., UK, and Europe, and partners and agents in China, South Korea, Turkey, Mexico, and more, Acta offers expertise with regulatory programs and chemical product approvals in North America, Europe, South and Central America, and Asia.

Our Firms

our people

Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, and five Ph.D.’s. Government affairs and regulatory specialists including four high-level EPA alumni. Business strategists with decades of experience directing worldwide regulatory compliance.

Acta consultants manage products from concept to approval, delivering skills and experience with specific product areas in government and industry.

Our three affiliated firms -- B&C, Acta, and BCCM -- provide a full range of global support for the commercialization of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.